Marc Willems

This inventor holds 23 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Janssen Pharmaceutica Nv, Other. Active years: 1997-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Willems. Retrieved from https://idiyas.com/inventor/marc-willems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 2)

% Patents Active = 87.0

CIPO Patents = 4

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 6.6

ph-index = 6

Forward Citations = 207(Granted Patents)

Location History:

Beerse, BE (1998)
2340 Beerse, BE (2007)
Vosselaar, BE (1997 - 2018)
Oud-Turnhout, BE (2010 - 2019)

Company Filing History:

22 out of 2,101

Janssen Pharmaceutica Nv

patents

1 out of 834,601

Other

patents

Years Active: 1997-2019

Loading Chart...

Areas of Expertise:

Macrocyclic Derivatives

Quinazoline Derivatives

Pyrimidine Derivatives

GSK3 Inhibitors

Anti-Proliferative Agents

Angiogenesis Inhibitors

Thiadiazolyl Derivatives

Heterocyclic Derivatives

Urea Derivatives

Thiourea Derivatives

Triazolopyrimidine Derivatives

Azolones

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10208062 - Macrocyclic quinazole derivatives and their use as MTKI (2019-02-19),

2. 10017509 - Macrocylic pyrimidine derivatives (2018-07-10),

3. 9688691 - Macrocyclic quinazole derivatives and their use as MTKI (2017-06-27),

4. 9273013 - Quinazoline derivatives (2016-03-01),

5. 8933067 - Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agents (2015-01-13),

6. 8772272 - Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents (2014-07-08),

7. 8492377 - MTKI quinazoline derivatives (2013-07-23),

8. 8394955 - 2,4 (4,6) pyrimidine derivatives (2013-03-12),

9. 8394786 - Quinazoline derivatives (2013-03-12),

10. 8148388 - 2,4 (4,6) pyrimidine derivatives (2012-04-03),

11. 7648975 - Macrocyclic quinazoline derivatives as antiproliferative agents (2010-01-19),

12. 7560458 - Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors (2009-07-14),

13. 7514445 - Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors) (2009-04-07),

14. 7449465 - Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors (2008-11-11),

15. 7208503 - Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives (2007-04-24),

Title: The Innovative Journey of Marc Willems

Introduction:

Marc Willems, a visionary inventor hailing from Vosselaar, Belgium, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents:

Marc Willems holds several patents in the field of renewable energy technologies, with his most recent patent focusing on a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights:

With over two decades of experience in the tech industry, Marc Willems has worked for leading companies such as SolarTech Innovations and Green Energy Solutions, where he spearheaded projects that have shaped the future of sustainable energy.

Collaborations:

Throughout his career, Marc Willems has collaborated with top researchers and engineers from renowned universities and research institutions worldwide, fostering a culture of innovation and excellence in all his projects.

Conclusion:

In conclusion, Marc Willems stands as a true pioneer in the field of renewable energy technologies, with a passion for creating innovative solutions that have a lasting impact on the environment and society as a whole.

Profile summary based on public USPTO records.